Speaker Profile
Ph.D., Founder, Kleiner Perkins
Biography
Brook Byers has been a venture capital investor since 1972. He has been closely involved with founders to help build more than 60 new science-based companies. He formed the first life sciences practice group in the venture capital profession in 1984 and led Kleiner Perkins to become a premier venture capital firm in the life sciences, healthcare and biotechnology sectors.Brook was the founding president and then chairman of four biotechnology companies that were incubated in Kleiner Perkins offices and went on to become public companies with an aggregate market value of more than US$8 billion. He currently serves on the board of directors of Arsenal Bio, Octave Bio, Newsela and Verana Health. Brook is a Lifetime Board Member of the University of California San Francisco Medical Center. He served on the Board of Trustees of Stanford University and the Georgia Tech Advisory Board. He received an Honorary PhD from Georgia Tech.
Session Abstract – PMWC 2026 Silicon Valley
Track Chair:
Mark Daly, Broad Institute (implied from context, but you didn’t restate – leaving just content here as requested)
PMWC Award Ceremony
• Mark Daly, Broad Institute
• Gordon Sanghera, Oxford Nanopore
The Data Factory: Building Systems to Integrate Millions of Genomes for Variant Interpretation
• Chair: Stephen B. Montgomery, Stanford
• Carlos D. Bustamante, University of Oklahoma
• Mark Daly, Broad Institute/FinnGen
• Manuel Rivas, Stanford
• Mark McCarthy, Genentech
• Nilah Ioannidis, UC Berkeley/UCSC
Beyond the Read: Integrating Long-Read Data into the Clinical Variant Pipeline
• Chair: Gordon Sanghera, Oxford Nanopore Technologies
• Hanlee P. Ji, Stanford
• Barrett Bready, Nabsys
Keynote: Biobanks and the Road Ahead in Human Genetics
• Mark Daly, Broad Institute/FinnGen
AI and Evolution for Predicting Human Disease Genes
• Chair: Yuval Tabach, Hebrew University
• Nilah Ioannidis, UC Berkeley/UCSC
• Sasa Jenko, European Commission
DNA to Drug, Label & Coverage: From Genetic Signals to Approval & Access
• Chair: Razelle Kurzrock, Medical College of Wisconsin
• Russ B Altman, Stanford
• Slavé Petrovski, AstraZeneca
• Wei Zhou, Broad Institute
25+ Years of the Human Genome — From Bench to Bedside to Beyond
• Chair: Ralph Snyderman, Duke
• J. Craig Venter, Craig Venter Institute (JCVI)
• Brook Byers, KPCB
• Lee Hood, Phenome Health
